Faidon Magkos1, David Bradley2, J Christopher Eagon2, Bruce W Patterson2, Samuel Klein3. 1. Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St. Louis, MO; Singapore Institute for Clinical Sciences, Agency for Science, Technology, and Research (A*STAR), and Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 2. Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St. Louis, MO; 3. Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St. Louis, MO; sklein@dom.wustl.edu.
Abstract
BACKGROUND: Data from studies conducted in animal models suggest that intestinal glucose uptake and metabolism are upregulated after Roux-en-Y gastric bypass (RYGB) surgery, which contributes to a weight-loss-independent improvement in glycemic control. OBJECTIVE: We conducted a cohort study to evaluate whether an increase in gastrointestinal metabolism of ingested glucose occurs in obese people who underwent RYGB compared with those who underwent laparoscopic adjustable gastric banding (LAGB). DESIGN: A mixed meal containing stable isotope-labeled glucose was used to determine the gastrointestinal (small intestine and liver) retention, and presumably metabolism, of ingested glucose in obese subjects before and after matched weight loss (∼21%) induced by RYGB (n = 16) or LAGB (n = 9). RESULTS: The total percentage of ingested glucose that appeared in the systemic circulation was slightly lower after than before RYGB (85% ± 9% and 90% ± 8%, respectively) but was slightly higher after than before LAGB (89% ± 3% and 85% ± 4%, respectively) (P-interaction < 0.05). Accordingly, gastrointestinal clearance of ingested glucose (cumulative percentage cleared over 6 h postprandially) increased after RYGB (from 10% ± 8% before to 15% ± 9% after surgery) but decreased after LAGB (from 15% ± 4% before to 11% ± 3% after surgery) (P < 0.05). Surgery-induced weight loss caused a similar decrease in the 6-h postprandial plasma glucose area under the curve in both RYGB and LAGB groups (-4% ± 9% and -6% ± 5%, respectively; P = 0.475). CONCLUSIONS: These data support the notion that intestinal glucose disposal increases after RYGB surgery. However, the magnitude of the effect was small and did not result in weight-loss-independent therapeutic effects on postprandial glycemic control. This trial was registered at clinicaltrials.gov as NCT00981500.
BACKGROUND: Data from studies conducted in animal models suggest that intestinal glucose uptake and metabolism are upregulated after Roux-en-Y gastric bypass (RYGB) surgery, which contributes to a weight-loss-independent improvement in glycemic control. OBJECTIVE: We conducted a cohort study to evaluate whether an increase in gastrointestinal metabolism of ingested glucose occurs in obesepeople who underwent RYGB compared with those who underwent laparoscopic adjustable gastric banding (LAGB). DESIGN: A mixed meal containing stable isotope-labeled glucose was used to determine the gastrointestinal (small intestine and liver) retention, and presumably metabolism, of ingested glucose in obese subjects before and after matched weight loss (∼21%) induced by RYGB (n = 16) or LAGB (n = 9). RESULTS: The total percentage of ingested glucose that appeared in the systemic circulation was slightly lower after than before RYGB (85% ± 9% and 90% ± 8%, respectively) but was slightly higher after than before LAGB (89% ± 3% and 85% ± 4%, respectively) (P-interaction < 0.05). Accordingly, gastrointestinal clearance of ingested glucose (cumulative percentage cleared over 6 h postprandially) increased after RYGB (from 10% ± 8% before to 15% ± 9% after surgery) but decreased after LAGB (from 15% ± 4% before to 11% ± 3% after surgery) (P < 0.05). Surgery-induced weight loss caused a similar decrease in the 6-h postprandial plasma glucose area under the curve in both RYGB and LAGB groups (-4% ± 9% and -6% ± 5%, respectively; P = 0.475). CONCLUSIONS: These data support the notion that intestinal glucose disposal increases after RYGB surgery. However, the magnitude of the effect was small and did not result in weight-loss-independent therapeutic effects on postprandial glycemic control. This trial was registered at clinicaltrials.gov as NCT00981500.
Authors: Hans J Woerle; Christian Meyer; Jean M Dostou; Niyaz R Gosmanov; Nazmul Islam; Emilia Popa; Steven D Wittlin; Stephen L Welle; John E Gerich Journal: Am J Physiol Endocrinol Metab Date: 2002-12-10 Impact factor: 4.310
Authors: B Capaldo; A Gastaldelli; S Antoniello; M Auletta; F Pardo; D Ciociaro; R Guida; E Ferrannini; L Saccà Journal: Diabetes Date: 1999-05 Impact factor: 9.461
Authors: Robyn A Tamboli; Reem M Sidani; Anna E Garcia; Joseph Antoun; James M Isbell; Vance L Albaugh; Naji N Abumrad Journal: Am J Physiol Endocrinol Metab Date: 2016-06-07 Impact factor: 4.310
Authors: María Belén Acevedo; Ramiro Ferrando; Bruce W Patterson; J Christopher Eagon; Samuel Klein; Marta Yanina Pepino Journal: Surg Obes Relat Dis Date: 2018-11-02 Impact factor: 4.734
Authors: Belén Pérez-Pevida; Javier Escalada; Alexander D Miras; Gema Frühbeck Journal: Front Endocrinol (Lausanne) Date: 2019-09-19 Impact factor: 5.555
Authors: Margaret A Stefater; Julian A Pacheco; Kevin Bullock; Kerry Pierce; Amy Deik; Enju Liu; Clary Clish; Nicholas Stylopoulos Journal: J Endocr Soc Date: 2020-01-23